EMFAT
LRMR icon

Emerald Mutual Fund Advisers Trust’s Larimar Therapeutics LRMR Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,583
Closed -$1.76M – 289
2015
Q3 		$1.76M Hold
4,583
– – 0.12% 156
2015
Q2 		$1.91M Hold
4,583
– – 0.15% 137
2015
Q1 		$1.88M Buy
4,583
+1,666
+57% +$791K 0.15% 133
2014
Q4 		$1.08M Hold
2,917
– – 0.09% 150
2014
Q3 		$688K Hold
2,917
– – 0.07% 172
2014
Q2 		$692K Buy
+2,917
New +$693K 0.06% 178

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's LRMR Position: Q4 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 4,583 shares — an estimated $1.76M sold.

Emerald Mutual Fund Advisers Trust first reported a position in LRMR in Q2 2014 and held it in 6 quarters. The position peaked at $1.91M in Q2 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Emerald Mutual Fund Advisers Trust reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 4,583 Larimar Therapeutics shares in Q4 2015, an estimated $1.76M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Larimar Therapeutics in Q2 2014 and held it in 6 quarters.
  • Emerald Mutual Fund Advisers Trust's Larimar Therapeutics position peaked at $1.91M in Q2 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2015, filed 25 Jan 2016.